Showing results (1211-1220 of 2,132) with videos related to

Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|December 2, 2000
Absorption and disposition including enterohepatic circulation of (14C) roquinimex after oral administration to healthy volunteersK Strandgården, P Höglund, L Grönquist, et al.
Biopharmaceutics & Drug Disposition|August 22, 2001
Comparative disposition of ricobendazole enantiomers after intravenous and subcutaneous administration of a racemic formulation to calvesC Cristòfol, G Virkel, L Alvarez, et al.
Biopharmaceutics & Drug Disposition|March 4, 2000
Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteersM J Lamson, J P Sabo, T R MacGregor, et al.
Biopharmaceutics & Drug Disposition|March 4, 2000
Disposition and exposure of the fibrinogen receptor antagonist XV459 on alphaIIBbeta3 binding sites in the guinea pigJ S Barrett, J Yu, R Kapil, et al.
Biopharmaceutics & Drug Disposition|April 13, 2000
The pharmacokinetics and metabolism of CP-191,166, an angiotensin II receptor antagonist, in rats and dogsM C Allen, M R Nocerini, W W Day
Biopharmaceutics & Drug Disposition|April 13, 2000
Dissolution rate-limited absorption and complete bioavailability of roquinimex in manK Strandgârden, P Höglund, O Nordle, et al.
Biopharmaceutics & Drug Disposition|April 17, 2001
Effect of naproxen co-administration on valproate dispositionR S Addison, S L Parker-Scott, W D Hooper, et al.
Biopharmaceutics & Drug Disposition|February 2, 2021
Pharmacokinetics of eperisone following oral administration in healthy Korean volunteersIn-Hwan Baek, Hyun-Moon Back, Jung-Woo Chae, et al.
Pageof 214